Chronic Obstructive Pulmonary Disease, a lung and airway disease, is mired in myths. Pulmonologist Dr Raja Dhar shares COPD facts to raise awareness. Chronic Obstructive Pulmonary Disease (COPD) is ...

Air pollution is rising at unprecedented rate which also increases your risk of developing COPD. Check out these expert-approved tips on how to protect lungs. World Health Organisation's November 2024 ...

World COPD Day is celebrated annually on the third Wednesday of November. This day aims to raise awareness about chronic obstructive pulmonary disease (COPD) and encourages better prevention and ...

Chronic obstructive pulmonary disease (COPD) was considered to be a condition that mostly affected older smokers. However, this is no longer the case. In several states across India, COPD is now ...

NEW YORK, NY – Nov. 19, 2025 – Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic sputum production and cough, claiming three ...

This year, World COPD Day 2025 will be observed on November 19, i.e tomorrow, under the theme "Short Of Breath, Think COPD" to focus on persistent breathlessness due to Chronic Obstructive Pulmonary ...

Dear Dr. Roach: I have hereditary hemochromatosis (HH) and atrial fibrillation. My AFib burden seems to vary with my iron levels. My AFib went from 58% to less than 2% in two weeks after I had a ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs and ...

Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade As ...

Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre ® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade ...

Researchers conducted a prospective randomized controlled trial in 74 patients with stage III-IV COPD and prior hospitalization to assess the safety and efficacy of using telemedicine for follow-up.